Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Eo2002 Low Dose

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT04894110Phase 1Completed

Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema

Showing all 1 trials

Research Network

Common Treatments

  • Eo2002 Low Dose1
  • Eo20021
  • Eo2002 Mid Dose1
  • Eo2002 High Dose1

Active Sponsors

  • Emmecell1

Top Investigators

Related Conditions

  • Bullous Keratopathy1
  • Corneal Endothelial Dystrophy1
  • Endothelial Dysfunction1
  • Fuchs Endothelial Corneal Dystrophy1
  • Corneal Endothelial Dysfunction1

Activity Timeline